Skip to main content

Table 3 Cluster analysis, mean instrument scores

From: Patient-reported outcomes measures of X-linked hypophosphataemia participants: findings from a prospective cohort study in the UK

Instrument

Cluster 1 (n = 11)

“Higher-score”

(mean)

Cluster 2 (n = 6)

“Lower-score”

(mean)

EQ-5D-5L

0.817

0.288

PSQI

7.64

12.67

SF-36-PCS

45.40

19.54

SF-36-MCS

51.31

43.40

SF-MPQ-2

1.03

3.58

painDETECT

5.64

14.17

Negative, n (%)

10 (90.91)

2 (33.33)

Unclear, n (%)

1 (9.09)

3 (50.00)

Positive, n (%)

0 (0.00)

1 (16.67)

FACIT-F

125.32

78.00

HADS-anxiety

6.73

6.50

Normal, n (%)

5 (45.45)

4 (66.67)

Mild, n (%)

5 (45.45)

1 (16.67)

Moderate/severe, n (%)

1 (9.09)

1 (16.67)

HADS-depression

3.18

8.17

Normal, n (%)

11 (100%)

3 (50.00)

Mild, n (%)

0

1 (16.67)

Moderate/severe, n (%)

0

2 (33.33)

  1. EQ-5D-5L, EuroQol 5 dimensions-5 levels; SF-36, Short-form 36; PCS, Physical Component Score; MCS, Mental Component Score; PSQI, Pittsburgh sleep quality index; FACIT-F, Functional assessment of chronic illness therapy-fatigue; SF-MPQ-2; Short form McGill pain questionnaire version 2; HADS, Hospital anxiety and depression scale